Cancer Treatment Transportation Help

Most people treat rides as a favor to ask friends. For many patients, a ride is a benefit instead. It comes with rules, deadlines, and an appeal path. Which rules apply depends on your insurance.

Sort that first. The answer for Medicaid and the answer for Medicare are not close to the same.

Federal rule 42 CFR 431.53 is short and blunt. A State plan must say that the Medicaid agency will ensure needed transportation to and from providers. It must also describe the methods the agency will use.

That is why every state Medicaid program has some form of ride benefit. It is usually called non-emergency medical transportation. Medicaid.gov lists Assurance of Transportation as its own policy topic.

The rule does not set the details. Each state writes its own methods. So the broker you call, the notice required, and the modes offered all vary. Ask your state Medicaid office or health plan three things. Who arranges rides? How many business days ahead must you call? Can a standing order cover a repeat schedule such as daily radiation?

Medicare does not cover routine rides to chemotherapy. Medicare Part B covers ambulance services, and the bar is set at medical need.

Medicare.gov sets two conditions for ground ambulance transport under Part B. Traveling in any other vehicle must be a danger to your health. And you must need care that is medically necessary. Covered stops include a hospital, a critical access hospital, a rural emergency hospital, or a skilled nursing facility. Medicare pays only to reach the nearest suitable facility.

Non-emergency ambulance rides can be covered too. That takes a written order from your doctor or other provider saying it is medically necessary. Medicare.gov gives regular dialysis trips as an example.

You pay 20% of the Medicare-approved amount after the Part B deductible. If the ambulance company thinks Medicare may not pay, it must give you an Advance Beneficiary Notice. Read that form before signing. It is telling you that you may owe the full bill.

The American Cancer Society runs Road To Recovery. Trained volunteer drivers give free rides to cancer-related appointments. There is no cost to the patient.

Three practical details decide whether it works for you.

Lead time. ACS says it can take several business days to coordinate a ride, so call well ahead of the appointment date. Do not call the night before.

Location. Availability differs by area. The only way to know is to ask about your area specifically.

Extra requirements. In some places a caregiver must come along. That can apply if the patient cannot walk alone or is under 18.

The number is 1-800-227-2345, and it is the same number ACS uses for lodging requests.

Some of the biggest wins are inside the building.

NCI names two roles to ask for by title. One is the financial counselor in the hospital billing office. The other is a social worker who knows programs beyond insurance. Both are usually free to see, and you can ask at any visit.

Ask them about parking validation, gas cards, and a travel fund. Then ask a scheduling question that often beats any voucher. Can visits be grouped on fewer days? Can any of them move to a site closer to home?

Radiation makes this urgent. A course delivered daily on weekdays for several weeks turns a 40-mile drive into hundreds of miles a month.

NCI's financial toxicity summary shows the wider squeeze. Recently diagnosed survivors aged 18 to 64 spent $1,107 a year out of pocket, in 2010 dollars. People with no cancer history spent $617. Between 22.5% and 64% reported stress and worry about paying medical bills.

Travel costs sit inside those numbers. They are easy to miss, because they arrive as gas, parking, and lost work hours rather than as a bill.

1. Write down your full treatment calendar first, including how many weeks and which days.
2. Call your Medicaid plan or broker and ask for a standing authorization for the whole course, not one trip at a time.
3. Call ACS at 1-800-227-2345 several business days before the first appointment you need covered.
4. Ask the clinic for a letter confirming your treatment schedule and dates. Programs move faster with documentation.
5. Keep a log of every denied or missed ride. Record the date, the number you called, and the name of the person you spoke to. An appeal is built from that log.
6. Tell the clinic the moment a ride falls through. Rescheduling is a clinical decision, and some treatments tolerate a gap better than others.

• Fever of 100.4 degrees F, or 38 degrees C, or higher during treatment. NCI treats this reading as the point to act on, and a fever while your counts are low is an emergency, not a scheduling problem. Ring the 24-hour oncology number at once and let them decide how you get in. If you cannot reach anyone, call 911 or get someone to drive you to an emergency department. Never sit at home waiting on a booked ride.
• Chest pain, trouble breathing, sudden weakness, confusion, or heavy bleeding. Call 911. Medicare covers ambulance transport when another vehicle would endanger your health.
• You are about to miss an infusion or a radiation session. Call the clinic, not just the ride service. They may hold the slot or move it.

• Does my plan cover non-emergency medical transportation, and who arranges it?
• How many business days of notice does that service require?
• Can one authorization cover my entire radiation course?
• Is Road To Recovery available in my county?
• Does this center have gas cards, parking validation, or a travel fund?
• Can my appointments be grouped to cut the number of trips?

For related reading, see Financial Assistance for Cancer, Housing Instability During Cancer Treatment, and Understanding Your Health Insurance.

• eCFR — 42 CFR 431.53, Assurance of Transportation
• Medicaid.gov — Benefits
• Medicare.gov — Ambulance Services Coverage
• American Cancer Society — Road To Recovery
• National Cancer Institute — Managing Cancer Care Costs
• National Cancer Institute — Financial Toxicity and Cancer Treatment (PDQ), Health Professional Version
• National Cancer Institute — Infection and Neutropenia during Cancer Treatment